Twelve recipients will each receive two-year grants of up to $1 million in Phase II funding to continue their efforts to develop new prevention and treatment technologies to combat malaria, HIV, and pneumonia. Now in its seventh round, the program has awarded grants to nearly five hundred researchers from over forty countries since it was launched in 2008.
Grant recipients in this funding round include Teun Bousema of Radboud University in the Netherlands, who is seeking to interrupt malaria transmission by deploying interventions at targeted transmission hotspots; Carmenza Spadafora of Panama's IASI and Jose Stoute of Pennsylvania State University, who are investigating whether malaria can be treated by microwave irradiation; and Fredros Okumu of the Ifakara Health Institute, who is exploring whether outdoor vector control devices can control malaria. The latter project is being funded jointly by Grand Challenges Canada and the Gates Foundation.
"Finding solutions to persistent global health problems is a difficult, lengthy, and expensive process," said Chris Wilson, director of global health discovery at the Gates Foundation. "GCE was designed to tap the innovators of the world by providing resources needed to explore bold ideas that are typically too risky to attract funding through other mechanisms. We're excited to enable further development of novel approaches that can prevent or lessen the burden of diseases that kill or disable millions of the world's most vulnerable."
For a complete list of projects funded in this round, visit the GCE Web site.